bnp levels Search Results


bnp levels measurement  (srl inc)
90
srl inc bnp levels measurement
Bnp Levels Measurement, supplied by srl inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pmc08787977-79-2-8?v=srl+inc
Average 90 stars, based on 1 article reviews
bnp levels measurement - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
baseline bnp levels  (Hamamatsu)
90
Hamamatsu baseline bnp levels
Comparison of middle-aged study participants with and without major adverse cardiovascular event during follow-up (2008–2016), Hamamatsu, Japan: Retrospective analysis.
Baseline Bnp Levels, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pmc10821589-189-6-22?v=Hamamatsu
Average 90 stars, based on 1 article reviews
baseline bnp levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
serum b-type natriuretic peptide (bnp) levels  (Siemens AG)
90
Siemens AG serum b-type natriuretic peptide (bnp) levels
Comparison of middle-aged study participants with and without major adverse cardiovascular event during follow-up (2008–2016), Hamamatsu, Japan: Retrospective analysis.
Serum B Type Natriuretic Peptide (Bnp) Levels, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pmc06788706-121-11-18?v=Siemens+AG
Average 90 stars, based on 1 article reviews
serum b-type natriuretic peptide (bnp) levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
elisa serum levels of bnp sea541mu  (USCN Life)
90
USCN Life elisa serum levels of bnp sea541mu
Comparison of middle-aged study participants with and without major adverse cardiovascular event during follow-up (2008–2016), Hamamatsu, Japan: Retrospective analysis.
Elisa Serum Levels Of Bnp Sea541mu, supplied by USCN Life, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pmc06431558-443-32-34?v=USCN+Life
Average 90 stars, based on 1 article reviews
elisa serum levels of bnp sea541mu - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
bnp levels  (Abbott Laboratories)
86
Abbott Laboratories bnp levels
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
Bnp Levels, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pmc12995573-58-6-16?v=Abbott+Laboratories
Average 86 stars, based on 1 article reviews
bnp levels - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
n-terminal pro bnp (ntprobnp) and ctnt levels  (Siemens AG)
90
Siemens AG n-terminal pro bnp (ntprobnp) and ctnt levels
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
N Terminal Pro Bnp (Ntprobnp) And Ctnt Levels, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm24731968-35-5-10?v=Siemens+AG
Average 90 stars, based on 1 article reviews
n-terminal pro bnp (ntprobnp) and ctnt levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
blood levels (bnp, cardiac enzymes)  (Esoterix Genetic Laboratories)
90
Esoterix Genetic Laboratories blood levels (bnp, cardiac enzymes)
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
Blood Levels (Bnp, Cardiac Enzymes), supplied by Esoterix Genetic Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm21982657-52-17-28?v=Esoterix+Genetic+Laboratories
Average 90 stars, based on 1 article reviews
blood levels (bnp, cardiac enzymes) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mr characterization of cardiac abnormalities in hiv+ individuals with increased bnp levels  (Breuckmann GmbH)
90
Breuckmann GmbH mr characterization of cardiac abnormalities in hiv+ individuals with increased bnp levels
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
Mr Characterization Of Cardiac Abnormalities In Hiv+ Individuals With Increased Bnp Levels, supplied by Breuckmann GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm27829660-126-29-1?v=Breuckmann+GmbH
Average 90 stars, based on 1 article reviews
mr characterization of cardiac abnormalities in hiv+ individuals with increased bnp levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
serum bnp level measurement  (Westminster Publications Inc)
90
Westminster Publications Inc serum bnp level measurement
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
Serum Bnp Level Measurement, supplied by Westminster Publications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm12232561-18-21-3?v=Westminster+Publications+Inc
Average 90 stars, based on 1 article reviews
serum bnp level measurement - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
serum bnp and ck-mb levels  (USCN Life)
90
USCN Life serum bnp and ck-mb levels
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
Serum Bnp And Ck Mb Levels, supplied by USCN Life, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm24996291-93-10-18?v=USCN+Life
Average 90 stars, based on 1 article reviews
serum bnp and ck-mb levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
l1 i stat tbi control level 1  (I-Stat Corporation)
86
I-Stat Corporation l1 i stat tbi control level 1
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
L1 I Stat Tbi Control Level 1, supplied by I-Stat Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/pm38326742-45-7-8?v=I-Stat+Corporation
Average 86 stars, based on 1 article reviews
l1 i stat tbi control level 1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
b type natriuretic peptide bnp levels  (Singulex Inc)
86
Singulex Inc b type natriuretic peptide bnp levels
Higher <t>Elevated</t> <t>Troponin-I</t> (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide <t>(BNP)</t> levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .
B Type Natriuretic Peptide Bnp Levels, supplied by Singulex Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bnp+levels/10__1016_slash_j__cardfail__2015__06__270-73-14-24?v=Singulex+Inc
Average 86 stars, based on 1 article reviews
b type natriuretic peptide bnp levels - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Comparison of middle-aged study participants with and without major adverse cardiovascular event during follow-up (2008–2016), Hamamatsu, Japan: Retrospective analysis.

Journal: Preventive Medicine Reports

Article Title: Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population

doi: 10.1016/j.pmedr.2024.102600

Figure Lengend Snippet: Comparison of middle-aged study participants with and without major adverse cardiovascular event during follow-up (2008–2016), Hamamatsu, Japan: Retrospective analysis.

Article Snippet: Kaplan-Meier analysis showing the influence of baseline BNP levels on the risk of major adverse cardiovascular events (MACE) in middle-aged study participants, Hamamatsu, Japan, 2008–2016.

Techniques: Comparison, Clinical Proteomics

Kaplan-Meier analysis showing the influence of baseline BNP levels on the risk of major adverse cardiovascular events (MACE) in middle-aged study participants, Hamamatsu, Japan, 2008–2016. Participants were divided into four groups according to the quartiles of baseline BNP levels (Q1–4). The median values and interquartile ranges are shown in the figure. Major adverse cardiovascular events are defined as cardiovascular death, non-fatal myocardial infarction, unstable angina, decompensated heart failure, stroke, and other cardiovascular events requiring hospitalization.

Journal: Preventive Medicine Reports

Article Title: Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population

doi: 10.1016/j.pmedr.2024.102600

Figure Lengend Snippet: Kaplan-Meier analysis showing the influence of baseline BNP levels on the risk of major adverse cardiovascular events (MACE) in middle-aged study participants, Hamamatsu, Japan, 2008–2016. Participants were divided into four groups according to the quartiles of baseline BNP levels (Q1–4). The median values and interquartile ranges are shown in the figure. Major adverse cardiovascular events are defined as cardiovascular death, non-fatal myocardial infarction, unstable angina, decompensated heart failure, stroke, and other cardiovascular events requiring hospitalization.

Article Snippet: Kaplan-Meier analysis showing the influence of baseline BNP levels on the risk of major adverse cardiovascular events (MACE) in middle-aged study participants, Hamamatsu, Japan, 2008–2016.

Techniques:

Higher Elevated Troponin-I (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide (BNP) levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .

Journal: JACC: Basic to Translational Science

Article Title: Methylated PIH1D1 as a Heart-Specific Biomarker for Anthracycline-Induced Cardiac Remodeling in Breast Cancer Patients

doi: 10.1016/j.jacbts.2026.101510

Figure Lengend Snippet: Higher Elevated Troponin-I (High-Sensitivity Cardiac Troponin I) Levels Are Associated With Reduced Ejection Fraction (A) High-sensitivity cardiac troponin I (hs-cTnI) and (B) B-type natriuretic peptide (BNP) levels were measured at baseline (pretreatment) and various post-treatment (3, 6, 12, and 24 months). The red line represents mean values at each time point; fold changes were calculated relative to the baseline. Individual patient trajectories are shown as gray lines, with the mean fold change highlighted in red. Longitudinal changes relative to baseline were analyzed using linear mixed-effects models accounting for within-patient correlation, with baseline-referenced post hoc contrasts adjusted for multiple comparisons. Fold changes of (C) LVESV, (D) LVEDV, (E) LVEF, and (F) LVS′ were relative to baseline over time points (3, 6, 12, 24, 30, and 36 months) in patients stratified by high-sensitivity cardiac troponin I levels: troponin ≥0.028 (red line) and troponin <0.028 (blue line). Each point represents an individual patient, with means shown by the lines for each group, and shaded areas represent the 95% CI. Between-group differences over time were analyzed using repeated-measures models accounting for within-patient correlation, with P values adjusted for multiple comparisons. Statistical significance is indicated by asterisks. Statistical significance is indicated by asterisks (∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001). Abbreviations as in .

Article Snippet: High-sensitivity cardiac troponin I (hs-cTnI) and BNP levels were measured using chemiluminescent microparticle immunoassays on the Abbott Architect platform (Abbott Laboratories). hs-cTnI was quantified using the Architect STAT High Sensitive Troponin-I assay, while BNP was measured using the Architect BNP assay.

Techniques: